Legal analysis identifies barriers to non-animal testing for chemical toxicity in the EU, suggesting implications for welfare and public health.
This report aims to identify the legal barriers to the transition toward non-animal testing in the assessment of chemical toxicity within the European Union, with particular attention to substances with endocrine-disrupting properties. To this end, it undertakes a comprehensive analysis of EU law, ranging from the foundational Treaties—which already enshrine binding obligations concerning, inter alia, animal welfare and public health protection—to the relevant secondary legislation. This is further complemented by an examination of the role and impact of EU executive acts and the activities of Union agencies.
No takes yet. Share an insight, caveat, or question.
Ton van den Brink (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: